US equities
|
SPCX
$144.75
▼-9.14%
MU
$856.49
▼-6.26%
NVDA
$212.21
▼-4.40%
META
$648.85
▼-6.98%
TSLA
$374.58
▼-3.08%
AAPL
$348.22
▲+1.23%
AMD
$507.93
▼-8.10%
SNDK
$1,260.93
▼-8.51%
SPCX
$144.75
▼-9.14%
MU
$856.49
▼-6.26%
NVDA
$212.21
▼-4.40%
META
$648.85
▼-6.98%
TSLA
$374.58
▼-3.08%
AAPL
$348.22
▲+1.23%
AMD
$507.93
▼-8.10%
SNDK
$1,260.93
▼-8.51%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:CYTK
Recent news which mentions NASDAQ:CYTK
CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
Tickers
CYTK
Tags
CYTK
NASDAQ:CYTK
Market News
From
InvestorPlace
CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
Tickers
CYTK
Tags
Market News
Earnings Reports
CYTK
From
InvestorPlace
CYTK Stock Flies High on Exciting Drug Trial Results
July 19, 2021
Tickers
CYTK
Tags
Market News
CYTK
Today's Market
From
InvestorPlace